DPP‐4 inhibitors vs sulphonylureas
Adverse events other than hypoglycaemia
It is very uncertain whether DPP‐4 inhibitors changes adverse events other than hypoglycaemia compared with sulphonylureas (very low certainty).
1 finding from 1 review
- Interventions for people with type 2 diabetes mellitus fasting during Ramadan 2023 · Cochrane Headline outcomes onlyRR 0.9 [0.52, 1.54]3 studies · 2426 participantsVery low